Open University PhD degree at Stowers Institute

Meet our Students

Student Selection Procedures

Registration with the Open University

PhD Student Research Degree Requirements

Student Responsibilities

Student Training

Student Advisory Committee

Annual Report Guidelines

Graduate Programme Coordinating Committee

Student Pastoral Support

 

Research Code of Conduct

Student Grievance Procedure

Nature of Studentship Appointment and Termination

SIMR specific documents
(internal access only)

Open University Resources

Forms

Guidance Notes

Calendar

OU's PhD Skill Course (need Password) SMT895

The Open UniversityOpen University (UK)

 

PhD degree at Stowers Institute for Medical Research

  

Chengqi LIN

Stowers Institute for Medical Research
An Affiliated Research Centre of the Open University

The Super Elongation Complex (SEC) in development and leukemogenesis

 

The mixed-lineage leukaemia gene (MLL) was found to form a variety of chromosomal translocations each resulting in the pathogenesis of acute myeloid and lymphoid leukaemia. Although these cytogenetic abnormalities were discovered over thirty years ago, little is known about the biochemical functions of MLL or how its translocations results in the development of leukaemia. The translocation partners of MLL share very little sequence or seemingly functional similarities. However, their translocations result in up-regulation of several genes within the Hox cluster and therefore the pathogenesis of leukaemia. To define the molecular reason why these translocations result in leukaemogenesis, my co-authors and I purified several of the commonly occurring MLL chimeras.  We have identified many of the MLL partners within a novel super elongation complex (SEC), including ELL, P-TEFb and AFF4.  AFF4 is required for SEC stability and proper transcription by poised RNA polymerase II in metazoans.  Knockdown of AFF4 within SEC in leukaemic cells shows reduction in MLL chimera target gene expression suggesting that AFF4 could be a key regulator in the pathogenesis of leukaemia through many of the MLL partners. We are in the process of identifying downstream targets of SEC in normal and leukaemic cells in the hope of developing targeted therapeutic for MLL translocation based leukaemia.

 

The Stowers Institute for Medical Research is a non-profit, basic biomedical research organization dedicated to improving human health by studying the fundamental processes of life. Jim Stowers, founder of American Century Investments, and his wife Virginia opened the Institute in 2000. Since then, the Institute has spent over a half billion dollars in pursuit of its mission. Currently the Institute is home to nearly 500 researchers and support personnel; over 20 independent research programs; and more than a dozen technology development and core facilities. Learn more about the Institute at www.stowers.org.

 

See also the Stowers Press Release on our website:

http://www.stowers.org/WhatsNew/pr2009/PR090109.asp

 

Opportunities to do PhD thesis work at Stowers Institute

Stowers Institute Home Page